PainReform (PRFX) Corporate Presentation from NobleCon18
News and Market Data on PainReform
NobleCon 18 Complete Rebroadcast
Access to Exclusive Content. FREE for Registered Users Only.
Join the Channelchek Investor Community to access equity research, video content, events, and much more. All at no cost.
‌
Share
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a...
Federal Reserve Chair Jerome Powell will take the stage at this week’s Jackson Hole Economic Symposium under some of the most difficult circumstances of his tenure, with markets, policymakers, and...
‌
8/20/2025
Health
Greenwich LifeSciences, Inc. (GLSI) – Initiating Coverage With An Outperform Rating and $45 Price Target
Greenwich LifeSciences Is Developing An Immunotherapy For Prevention Of Breast Cancer Recurrence. Greenwich LifeSciences is a biotechnology company developing GSLI-100, an immunotherapy based on HER2/neu. GLSI-100 completed four clinical trials that...
‌
8/20/2025
Media and Entertainment
Snail (SNAL) – Building The Foundation For StableCoin
Disappointing Q2. Total company revenues of $22.2 million increased nearly 3% over the prior year earlier period, but was lighter than our $26.0 million estimate. The variance was largely attributable to...
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.
